What question did this study set out to answer?

To compare non-implantable neuromodulation therapies with conventional treatments for major depression.

February 6, 2026

Non-implantable neuromodulation therapies compared to conventional treatments for major depression

Key Points

To compare non-implantable neuromodulation therapies with conventional treatments for major depression.
Evaluated the effectiveness of neuromodulation therapies alongside pharmacotherapy.
Analyzed the integration of treatment approaches for optimal outcomes.
Considered patient tolerability and functional recovery as key factors.
Non-implantable therapies were found to be effective in clinical settings.
Combining these therapies with conventional treatments improved overall patient outcomes.
Integration of neuromodulation with pharmacotherapy enhanced response rates.

Abstract

Non-implantable neuromodulation therapies are evolving from experimental interventions to validated clinical options. Rather than competing with pharmacotherapy, they should be viewed as complementary components within a multimodal framework. The future of depression management likely depends on the integration of pharmacological and neuromodulatory approaches to optimize response, tolerability, and functional recovery.

Perguntar à IA

Bookmark